Cannabinoidi e l’epilessia

Robert Fisher, and other. →  ILAE Official Report: A practical clinical definition of epilepsy. April 2014 Volume 55, Issue 4 Pages 471–626, e25–e33.

 Devinsky O and other.  → Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016 Mar;15(3):270-8. Devinsky O and other.  → Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014 Jun;55(6):791-802

 Bergamaschi MM, Queiroz RH, Zuardi AW, Crippa JA → Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011 Sep 1;6(4):237-49.

 Devinsky O and other. →  Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016 Mar;15(3):270-8.

 Fabio Arturo Iannotti and other.  → Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability. ACS Chem. Neurosci.,